Evidence map›Paper›PMID 37353674›Full record

ArticleJournal of natural medicines2023

Lobetyolin, a Q-marker isolated from Radix Platycodi, exerts protective effects on cisplatin-induced cytotoxicity in HEK293 cells.

Yun-Yi Hou, Si-Min Qi, Jing Leng, Qiong Shen, Shan Tang, Jing-Tian Zhang, Jun-Nan Hu, Shuang Jiang, Wei Li

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of natural medicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Frontiers in nutrition · 2025
    Review
  5. Quality Assessment and Classification ofMolecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yun-Yi HouCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China.
Si-Min QiCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China.
Jing LengCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China.
Qiong ShenCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China.
Shan TangCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China.
Jing-Tian ZhangCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China.
Jun-Nan HuCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China.
Shuang JiangCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China. jiangshuang0503@hotmail.com.
Wei LiCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China. liwei7727@126.com.ORCID http://orcid.org/0000-0002-2988-4298
Jilin Agricultural University · CN

Funding

Jilin Science & Technology Development Plan No. 20160209008YY
6 · The paper itself

Abstract

This study investigated the protective effect of lobetyolin (LBT), a Q-marker isolated from the roots of Platycodon grandiflorum (Radix Platycodi), against cisplatin-induced cytotoxicity in human embryonic kidney (HEK293) cells. Results showed that LBT at 20 μM significantly prevented cisplatin-induced cytotoxicity by improving the viability of HEK293 cells, decreasing levels of MDA, and decreasing GSH content triggered by cisplatin. It also suppressed reactive oxygen species (ROS) levels. Molecular docking analysis revealed a strong binding affinity between LBT and the NF-κB protein, with a docking fraction of - 6.5 kcal/mol. These results provide compelling evidence suggesting a potential link between the visualization analysis of LBT and its protective mechanism, specifically implicating the NF-κB signaling pathway. LBT also reduced the expression level of tumor necrosis factor-alpha (TNF-α), phosphorylation NF-κB and IκBα in HEK293 cells which were increased by cisplatin exposure, leading to inhibition of inflammation. Furthermore, western blotting showed that LBT antagonized the up-regulation of Bax, cleaved caspase 3, 8, and 9 expression and inhibited the MAPK signaling pathway by down-regulating phosphorylation JNK, ERK, and p38, partially ameliorating cisplatin-induced cytotoxicity in HEK293 cells. Therefore, these results indicate that LBT has potentially protected renal function by inhibiting inflammation and apoptosis.

Indexed as

CisplatinNF-kappa BApoptosisHEK293 CellsHumansInflammationMolecular Docking SimulationPlant ExtractsPlatycodonPolyynesTumor Necrosis Factor-alphaCisplatinlobetyolinNF-kappa BPlant Extractsplatycodon root extractPolyynesTumor Necrosis Factor-alphaApoptosisCisplatinCytotoxicityInflammationLobetyolinMAPK pathways

Identifiers

PMID37353674
OpenAlexW4381838901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.